Clinical Trial Update: Assess Safety and Efficacy of Levetiracetam(LEV;Keppra)for Seizure Prevention [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating safety and efficacy of levetiracetam (Keppra) for seizure prevention in patients with traumatic brain injury or subarachnoid hemorrhage…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subarachnoid Hemorrhage
• Traumatic Brain Injury

Drugs mentioned

• Keppra (levetiracetam)

Snippet

Sponsor: University of Cincinnati | Conditions: Traumatic Brain Injury, Subarachnoid Hemorrhage | Phase 4 | Status: COMPLETED | Results posted: 2014-04-07